Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.20    -5.80 (-5.32%)
Bid:
103.00
Ask:
104.20
Spread: 1.20 (1.165%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

FRS 101 Notification

10 Feb 2016 07:00

RNS Number : 4117O
Synthomer PLC
10 February 2016
 

NOTIFICATION TO SHAREHOLDERS IN ACCORDANCE WITH FRS 101

Synthomer plc has today posted a letter to shareholders, the full text of which is set out below.

 

 

Dear Shareholder

 

NOTIFICATION TO SHAREHOLDERS IN ACCORDANCE WITH FRS 101

 

On 1 January 2015 a new UK GAAP reporting regime became effective and, as a result, Synthomer plc ("the Company"), the parent company of the Synthomer Group, is obliged to transition to a replacement accounting framework for its financial statements for the financial year ended 31 December 2015. Accordingly, consistent with UK listed company market practice, your Board has decided to adopt FRS 101 "Reduced Disclosure Framework" for its Company financial statements. In this connection it is possible to elect to take advantage of disclosure exemptions, however, the Company disclosures are expected to be the same as, or follow closely, those reported under previous UK GAAP. There is no change to the accounting framework for the Group's consolidated financial statements, which will continue to be prepared in accordance with International Financial Reporting Standards, as adopted in the European Union.

 

Whilst your Board's decision does not require shareholder approval we are required under the rules issued by the Financial Reporting Council to inform our shareholders about the adoption of FRS 101, and to provide a reasonable opportunity for our shareholders to object. You do not need to reply to this letter, but any shareholder or shareholders holding in aggregate 5% or more of the total allotted shares in Synthomer plc can object to the adoption of FRS 101, if they wish to do so, by writing to the Company Secretary at Synthomer plc, Central Road, Harlow, Essex, CM20 2BH before 26 February 2016.

 

The election will apply on an ongoing basis until such time as the Company notifies shareholders of any change to its chosen accounting framework for its financial statements.

 

Contact: Richard Atkinson, Company Secretary

Stephen Bennett, Chief Financial Officer

UK Switchboard: +44 (0)1279 436 211

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSFFLAFMSEIE
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.